Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sweden issues genetic testing guidelines to aid healthcare staff facing ethical dilemmas

This article was originally published in Clinica

Executive Summary

Children should only undergo presymptomatic testing for a hereditary genetic disease if effective treatment exists for the disease, say new guidelines from Sweden's National Board of Health and Welfare. The guidelines, included in a report published last week on the ethical issues involved in genetic testing, recommend that informed consent should always be obtained before genetic testing takes place and that psychological support is made available to patients and their families.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT079261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel